{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:37:41Z","timestamp":1763015861107,"version":"3.45.0"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015763","name":"Szegedi Tudom\u00e1nyegyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Generally, the pregnant women with schizophrenia have higher consumption of medicinal drugs. During pregnancy, placental ABC transporters regulate drug disposition and are involved in fetal and placental development. This study examined the expression and function of placental P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) transporters\n                      <jats:italic>in vivo<\/jats:italic>\n                      and evaluated the epigenetic impact of schizophrenia on the placenta in a rat model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The expression of placental P-gp and BCRP was measured by RT-PCR and Western blot techniques in schizophrenia-like Wisket and control Wistar rats on gestation days 15, 18, 20, 21, and 22, while the histone acetyltransferase activity and global methylation state of the placenta were detected by colorimetric kits. Fexofenadine was administered\n                      <jats:italic>per os<\/jats:italic>\n                      (10\u00a0mg\/kg) to pregnant rats and plasma concentrations of fexofenadine were determined with HPLC analysis on the 21 and 22 days of gestation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Reduced placental P-gp expression was identified in late pregnancy, while the placental BCRP expression upregulation was observed before term in schizophrenia. Significantly lower fetal fexofenadine plasma concentration was measured on the 21st and 22nd days of pregnancy compared to the mother; in contrast, the fexofenadine concentration was similar in the schizophrenia-like mother and fetus. Decreased placental histone acetyltransferase activity and DNA hypermethylation were revealed before term in schizophrenia-like rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Based on our results, we can conclude that the expression and function of the placental efflux proteins we examined are altered in schizophrenia, and possibly as a result, altered substrate concentrations were measured in the fetuses. We hypothesize that the altered protein expression may also be a result of the disease-induced epigenetic pattern changes. This study presents novel disease-associated placental ABC transporter alterations, which highlights the dangers of using transporter substrates, especially P-gp, during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1673124","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:29:44Z","timestamp":1763015384000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Changed expression of placental transporters and disrupted epigenetic patterns in a rat model of schizophrenia"],"prefix":"10.3389","volume":"16","author":[{"given":"P\u00e9ter","family":"Szatm\u00e1ri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienn","family":"Seres-Bokor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Sztojkov-Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"K\u00e9kesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6ngyi","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter","family":"Ducza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e201316","DOI":"10.1001\/jamapediatrics.2020.1316","article-title":"Association between fexofenadine use during pregnancy and fetal outcomes","volume":"174","author":"Andersson","year":"2020","journal-title":"JAMA Pediatr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1124\/dmd.111.040626","article-title":"Mechanisms of reduced maternal and fetal lopinavir exposure in a rat model of gestational diabetes","volume":"39","author":"Anger","year":"2011","journal-title":"Drug Metabolism Dispos."},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40501-019-0165-5","article-title":"Use of antipsychotic drugs during pregnancy","volume":"6","author":"Betcher","year":"2019","journal-title":"Curr. Treat. Options Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1365\/s10337-008-0526-5","article-title":"LC\u2013MS\u2013MS assay for simultaneous quantification of fexofenadine and pseudoephedrine in human plasma","volume":"67","author":"Bharathi","year":"2008","journal-title":"Chromatographia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e12507","DOI":"10.1111\/gbb.12507","article-title":"Impaired GAD1 expression in schizophrenia\u2010related WISKET rat model with sex\u2010dependent aggressive behavior and motivational deficit","volume":"18","author":"B\u00fcki","year":"2019","journal-title":"Genes, Brain Behav."},{"key":"B6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/dmd.119.090316","article-title":"Role of Oatp2b1 in drug absorption and drug-drug interactions","volume":"48","author":"Chen","year":"2020","journal-title":"Drug Metabolism Dispos. Biol. Fate Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1006\/abio.1987.9999","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate\u2013phenol\u2013chloroform extraction","volume":"162","author":"Chomzynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.placenta.2020.09.004","article-title":"Global DNA methylation in placental tissues from pregnant with preeclampsia: a systematic review and pathway analysis","volume":"101","author":"Cruz","year":"2020","journal-title":"Placenta"},{"key":"B9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.toxlet.2008.03.007","article-title":"Role of breast cancer resistance protein (Bcrp\/Abcg2) in fetal protection during gestation in rat","volume":"178","author":"Cygalova","year":"2008","journal-title":"Toxicol. Lett."},{"key":"B10","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/pharmaceutics16070884","article-title":"Altered expression of BCRP impacts fetal accumulation of Rosuvastatin in a rat model of Preeclampsia","volume":"16","author":"Dai","year":"2024","journal-title":"Pharmaceutics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"S70-S81","DOI":"10.1002\/jcph.1491","article-title":"Drug transporters expressed in the human placenta and models for studying maternal-fetal drug transfer","volume":"59","author":"Dallmann","year":"2019","journal-title":"J. Clin. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s40264-015-0299-3","article-title":"P-Glycoprotein-Mediated drug interactions in pregnancy and changes in the risk of congenital anomalies: a case-reference Study","volume":"38","author":"Daud","year":"2015","journal-title":"Drug Saf."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0173530","DOI":"10.1371\/journal.pone.0173530","article-title":"Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies","volume":"12","author":"Daud","year":"2017","journal-title":"PLOS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/YCO.0000000000000706","article-title":"Schizophrenia during pregnancy","volume":"34","author":"Dazzan","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/genes15030272","article-title":"Epigenetic regulation in schizophrenia: focus on methylation and histone modifications in human studies","volume":"15","author":"Delphin","year":"2024","journal-title":"Genes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41598-020-57725-0","article-title":"Being born large for gestational Age is associated with increased global placental DNA methylation","volume":"10","author":"Dwi Putra","year":"2020","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/neurolint14010005","article-title":"Antipsychotic use in pregnancy: patient mental health challenges, teratogenicity, pregnancy complications, and postnatal risks","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol. Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3727\/000000001783992731","article-title":"DNA methylation and histone deacetylation in the control of gene expression: basic biochemistry to human development and disease","volume":"9","author":"El-Osta","year":"2001","journal-title":"Gene Expr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/bcp.14191","article-title":"Placental transporter\u2010mediated drug interactions and offspring congenital anomalies","volume":"86","author":"Ellfolk","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"Disease\u2010Associated changes in drug transporters May impact the pharmacokinetics and\/or toxicity of drugs: a white paper from the international transporter consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin. Pharmacol. & Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"100209","DOI":"10.1016\/j.lanepe.2021.100209","article-title":"Pregnancy, delivery and neonatal complications in women with schizophrenia: a national population-based cohort Study","volume":"10","author":"Fabre","year":"2021","journal-title":"Lancet Regional Health - Eur."},{"key":"B22","unstructured":"FDA\u2019s examples of drugs that interact with CYP enzymes and transporter systems, table of substrates, inhibitors and inducers. Table 1: CYP Enzyme- and transporter system-based clinical substrates, inhibitors, or inducers\n          \n          \n          2025"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1002\/rcm.5111","article-title":"Quantification of the transporter substrate fexofenadine in cell lysates by liquid Chromatography\/Tandem mass spectrometry","volume":"25","author":"Flynn","year":"2011","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000495063","article-title":"Epigenetic factors in schizophrenia: mechanisms and experimental approaches","volume":"5","author":"F\u00f6cking","year":"2019","journal-title":"Complex Psychiatry"},{"key":"B25","article-title":"FDA, bioanalytical method validation: guidance for industry, 2018","year":"2018","journal-title":"Food Drug Adm."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s11095-022-03165-6","article-title":"Limited impact of Murine placental MDR1 on fetal exposure of certain drugs explained by bypass transfer between adjacent Syncytiotrophoblast layers","volume":"39","author":"Fujita","year":"2022","journal-title":"Pharm. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"771818","DOI":"10.3389\/fphar.2021.771818","article-title":"Organic anion transporting polypeptide 2B1 in human fetal membranes: a novel gatekeeper for drug transport during pregnancy?","volume":"12","author":"Ganguly","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40262-024-01470-4","article-title":"Improving understanding of fexofenadine pharmacokinetics to assess Pgp phenotypic activity in older adult patients using population pharmacokinetic modeling","volume":"64","author":"Gaspar","year":"2025","journal-title":"Clin. Pharmacokinet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12958-020-00637-5","article-title":"Histone acetylation and the role of histone deacetylases in normal cyclic endometrium","volume":"18","author":"Gujral","year":"2020","journal-title":"Reproductive Biol. Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1080\/15592294.2022.2111755","article-title":"Placental DNA methylation in pregnancies complicated by maternal diabetes and\/or obesity: state of the art and research gaps","volume":"17","author":"Hjort","year":"2022","journal-title":"Epigenetics"},{"key":"B31","unstructured":"ICH M12 on drug Interaction Studies - scientific Guideline\n          \n          \n          2022"},{"key":"B32","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3109\/00498254.2010.506929","article-title":"Pharmacokinetics of fexofenadine following LPS administration to rats","volume":"40","author":"Jaisue","year":"2010","journal-title":"Xenobiotica"},{"key":"B33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(21)01730-X","article-title":"Schizophrenia","volume":"399","author":"Jauhar","year":"2022","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e1003515","DOI":"10.1371\/journal.pgen.1003515","article-title":"Global DNA hypermethylation in Down Syndrome placenta","volume":"9","author":"Jin","year":"2013","journal-title":"PLoS Genet."},{"key":"B35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbr.2015.02.015","article-title":"Sex-Specific alterations in behavioral and cognitive functions in a \u2018Three Hit\u2019 animal model of schizophrenia","volume":"284","author":"Kekesi","year":"2015","journal-title":"Behav. Brain Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1124\/dmd.121.000449","article-title":"Regulation of placental efflux transporters during pregnancy complications","volume":"50","author":"Kozlosky","year":"2022","journal-title":"Drug Metabolism Dispos."},{"key":"B37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0890-6238(98)00027-6","article-title":"Placental P-Glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice","volume":"12","author":"Lankas","year":"","journal-title":"Reprod. Toxicol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0890-6238(98)0027-6","article-title":"Placental P-Glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice","volume":"12","author":"Lankas","year":"","journal-title":"Reprod. Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1124\/dmd.31.2.153","article-title":"The presence of xenobiotic transporters in Rat Placenta","volume":"31","author":"Leazer","year":"2003","journal-title":"Drug Metabolism Dispos. Biol. Fate Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.12997\/jla.2020.9.3.419","article-title":"The key role of DNA methylation and histone acetylation in epigenetics of atherosclerosis","volume":"9","author":"Lee","year":"2020","journal-title":"J. Lipid Atheroscler."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3390\/ijms22042032","article-title":"Increased histone acetylation and decreased expression of specific histone deacetylases in ultraviolet-irradiated and intrinsically aged human skin in vivo","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.devcel.2021.04.011","article-title":"Epigenetic States in the human placenta: a singular epigenome for an exceptional tissue","volume":"56","author":"Lesch","year":"2021","journal-title":"Dev. Cell"},{"key":"B43","article-title":"Drug transporters in drug disposition, effects and toxicity. With Guoyu pan","author":"Liu","year":"2019"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0313705","DOI":"10.1371\/journal.pone.0313705","article-title":"Prenatal stress increases corticosterone levels in offspring by impairing placental glucocorticoid barrier function","volume":"20","author":"Liu","year":"2025","journal-title":"PLOS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11033-023-09005-z","article-title":"Global DNA methylation and miR-126-3p expression in Mexican women with gestational diabetes mellitus: a pilot Study","volume":"51","author":"Liz\u00e1rraga","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e23959","DOI":"10.7759\/cureus.23959","article-title":"Neurobiology of schizophrenia: a comprehensive review","volume":"14","author":"Luvsannyam","year":"2022","journal-title":"Cureus"},{"key":"B47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.molmed.2022.11.001","article-title":"ABC transporters: human disease and pharmacotherapeutic potential","volume":"29","author":"Moore","year":"2023","journal-title":"Trends Mol. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"328.e1","DOI":"10.1016\/j.ajog.2024.06.011","article-title":"The Placenta in fetal death: molecular evidence of dysregulation of inflammatory, proliferative, and fetal protective pathways","volume":"232","author":"Nardi","year":"2025","journal-title":"Am. J. Obstetrics Gynecol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.xphs.2023.11.006","article-title":"Breast cancer resistance protein limits fetal transfer of Tadalafil in mice","volume":"113","author":"Nishimura","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.reprotox.2004.04.014","article-title":"P-Glycoprotein expression and distribution in the rat placenta during pregnancy","volume":"18","author":"Novotna","year":"2004","journal-title":"Reprod. Toxicol."},{"key":"B51","first-page":"638","article-title":"Schizophrenia: overview and treatment options","volume":"39","author":"Patel","year":"2014","journal-title":"P & T A Peer-Reviewed J. Formulary Manag."},{"key":"B52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bbr.2012.11.022","article-title":"Characterization of gene\u2013environment interactions by behavioral profiling of selectively bred rats: the effect of NMDA receptor inhibition and social isolation","volume":"240","author":"Petrovszki","year":"2013","journal-title":"Behav. Brain Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11095-021-03035-7","article-title":"Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model","volume":"38","author":"Pinto","year":"2021","journal-title":"Pharm. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10517-023-05723-3","article-title":"Functioning of P-Glycoprotein during pregnancy in rabbits","volume":"174","author":"Popova","year":"2023","journal-title":"Bull. Exp. Biol. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ejps.2009.03.012","article-title":"Pharmacokinetic drug interaction between fexofenadine and fluvastatin mediated by organic anion-transporting polypeptides in rats","volume":"37","author":"Qiang","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13148-016-0247-9","article-title":"Increased global placental DNA methylation levels are associated with gestational diabetes","volume":"8","author":"Reichetzeder","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.schres.2020.03.048","article-title":"Antipsychotic drug use in pregnancy: a multinational Study from ten countries","volume":"220","author":"Reutfors","year":"2020","journal-title":"Schizophrenia Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"S295028532300011X","DOI":"10.1016\/j.sjpmh.2023.04.002","article-title":"Maternity in women with schizophrenia and schizoaffective disorder","author":"Safont","year":"2023","journal-title":"Span. J. Psychiatry Ment. Health"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1073\/pnas.94.8.4028","article-title":"Normal viability and altered pharmacokinetics in mice lacking Mdr1-Type (Drug-Transporting) P-Glycoproteins","volume":"94","author":"Schinkel","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.bbagrm.2010.08.012","article-title":"Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases","volume":"1799","author":"Selvi","year":"2010","journal-title":"Biochimica Biophysica Acta (BBA) - Gene Regul. Mech."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2020.95422","article-title":"Placental DNA methylation in caesarean sections \u2013 a pilot study","author":"S\u0142abuszewska-J\u00f3\u017awiak","year":"2020","journal-title":"Archives Med. Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1038\/s41380-019-0601-3","article-title":"Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings","volume":"25","author":"Smigielski","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1172\/JCI7963","article-title":"Absence or pharmacological blocking of placental P-Glycoprotein profoundly increases fetal drug exposure","volume":"104","author":"Smit","year":"1999","journal-title":"J. Clin. Investigation"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/s41380-023-02138-4","article-title":"Incidence, prevalence, and global burden of Schizophrenia - data, with critical appraisal, from the global burden of disease (GBD) 2019","volume":"28","author":"Solmi","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"R1505","DOI":"10.1152\/ajpregu.00279.2003","article-title":"Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat","volume":"287","author":"St-Pierre","year":"2004","journal-title":"Am. J. Physiology. Regul. Integr. Comp. Physiology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1017\/S1092852918001013","article-title":"Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate","volume":"23","author":"Stahl","year":"2018","journal-title":"CNS Spectrums"},{"key":"B67","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1517\/17425255.2015.1005073","article-title":"Regulation of drug transporter expression and function in the placenta","volume":"11","author":"Staud","year":"2015","journal-title":"Expert Opin. Drug Metabolism & Toxicol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"13089","DOI":"10.3390\/ijms241713089","article-title":"Changes in expression and function of placental and intestinal P-Gp and BCRP transporters during pregnancy","volume":"24","author":"Szatm\u00e1ri","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.3390\/ijms26146976","article-title":"Alterations in P-Glycoprotein expression in the placenta of obese rats and humans","volume":"26","author":"Szatm\u00e1ri","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"241","DOI":"10.37349\/ec.2024.00037","article-title":"Epigenetic mechanisms linking pregnancy complications to cardiovascular disease in offspring","volume":"2","author":"Talpur","year":"2024","journal-title":"Explor. Cardiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12888-017-1475-z","article-title":"Dilemma of treating schizophrenia during pregnancy: a case series and a review of literature","volume":"17","author":"Teodorescu","year":"2017","journal-title":"BMC Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1176\/appi.ajp.2018.17091001","article-title":"20-Year nationwide Follow-Up Study on discontinuation of antipsychotic treatment in first-episode schizophrenia","volume":"175","author":"Tiihonen","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"B73","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41372-024-02060-9","article-title":"Increased risk of severe neonatal opioid withdrawal syndrome in pregnancies with low placental ABCB1 DNA methylation","volume":"45","author":"Townsel","year":"2025","journal-title":"J. Perinatology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fnins.2015.00297","article-title":"Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management","volume":"9","author":"Ventriglio","year":"2015","journal-title":"Front. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"107813","DOI":"10.1016\/j.phrs.2025.107813","article-title":"The roles of histone acetylation key enzymes HAT, HDAC and BET proteins in neuropathic pain: selection of drug targets","volume":"217","author":"Wang","year":"2025","journal-title":"Pharmacol. Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.placenta.2015.08.007","article-title":"The effect of maternal obesity on the expression and functionality of placental P-Glycoprotein: implications in the individualized transplacental digoxin treatment for fetal heart failure","volume":"36","author":"Wang","year":"2015","journal-title":"Placenta"},{"key":"B78","volume-title":"World health Organization (WHO)","year":"2025"},{"key":"B79","doi-asserted-by":"publisher","first-page":"13149","DOI":"10.3390\/ijms222313149","article-title":"Overview of drug transporters in human placenta","volume":"22","author":"Yamashita","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3390\/ijms18081689","article-title":"New targets for schizophrenia treatment beyond the dopamine Hypothesis","volume":"18","author":"Yang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12991-025-00557-x","article-title":"Epigenetics factors in schizophrenia: future directions for etiologic and therapeutic study approaches","volume":"24","author":"Yang","year":"2025","journal-title":"Ann. General Psychiatry"},{"key":"B82","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/bmc.2712","article-title":"Quantification of fexofenadine in biological matrices: a review of bioanalytical methods","volume":"26","author":"Yao","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1271\/bbb.69.1871","article-title":"Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation","volume":"69","author":"Yasuda","year":"2005","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.3390\/cells9102281","article-title":"Aberrant DNA methylation of ABC transporters in cancer","volume":"9","author":"Zappe","year":"2020","journal-title":"Cells"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1629032","DOI":"10.3389\/fpsyt.2025.1629032","article-title":"Results of the Global Burden of disease Study for Schizophrenia: trends from 1990 to 2021 and Projections to 2050","volume":"16","author":"Zhan","year":"2025","journal-title":"Front. Psychiatry"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1124\/dmd.107.018044","article-title":"Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the Pregnant mouse","volume":"35","author":"Zhang","year":"2007","journal-title":"Drug Metabolism Dispos. Biol. Fate Chem."},{"key":"B87","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1124\/mol.107.041616","article-title":"The breast cancer resistance protein (Bcrp1\/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an obstetric-fetal pharmacology research unit network and University of Washington Specialized Center of research Study","volume":"73","author":"Zhou","year":"2008","journal-title":"Mol. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1673124\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:29:48Z","timestamp":1763015388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1673124\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":87,"alternative-id":["10.3389\/fphar.2025.1673124"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1673124","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"article-number":"1673124"}}